UK on OTC ads
This article was originally published in The Tan Sheet
Executive Summary
Guidelines for advertisements promoting OTCs for previously restricted indications are expected by year-end, UK's Medicines & Healthcare Products Regulatory Agency announces Aug. 11. Under the new guidelines, aspirin may be promoted for secondary prevention of heart attacks, while calcium and vitamin D products may be touted to prevent osteoporosis. Agency proposed amending the 1994 regulations in a November 2002 consultation letter (1"The Tan Sheet" Nov. 11, 2002, p. 17). Forty-one comments were received, of which 13 opposed removal of the restrictions and 31 supported the initiative...
You may also be interested in...
Aspirin Ad Claims For Cardiovascular Benefits Allowed In UK Proposal
Promoting aspirin 75 mg to consumers for secondary prevention of heart attack or stroke would be permitted in the UK under a proposal issued for consultation by the country's Medicines Control Agency Nov. 4
Synthekine Joins Quest To Tame IL-2 In Cancer Therapies
First clinical data from Synthekine’s IL-2 candidate and that of rivals Medicenna were presented at the AACR, suggesting there’s life in the modality yet.
Swisse Supplements Take Bigger Slice Of Chinese Market
Australian-heritage Swisse grew its share of China's supplements market in 2023 by delivering tailored products to an increasingly health conscious population.